Clene Inc.
CLNN Nasdaq· Pharmaceutical Preparations
Last close · Oct 27, 2026
$3.97
KIRA · Stoqly’s AI analyst, in plain words
- Clene Inc. had $0.2M of revenue in fiscal 2025, down 41.5% on the year before. Over five years, revenue changed −0.6% a year on average.
- Its operating margin was −11,541.5%, down 1,865.2 pts: of every 100 in sales, about −11,542 is left after running the business.
- Clene Inc. lost $26.2M in fiscal 2025.
- Free cash flow was −$18.6M in fiscal 2025, −9,292.5% of revenue.
- Clene Inc. owes $12.6M more than it holds in cash.
Market cap
—
P/E
—
Revenue
$0.2M
Net income
−$26.2M
Free cash flow
−$18.6M
Operating margin
−11,541.5%
Clene Inc. in 30 seconds · fiscal 2025
Are sales growing?
−41.5%
No. Sales fell 41.5% last year.
Does it make a profit?
−13,086.5%
No. It lost money last year.
Does profit turn into cash?
−9,292.5%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
What Clene Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 17, 2026
- Legal name
- Clene Inc.
- CIK
- 0001822791
Clene Inc. · CLNN
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.7M | $0.5M | $0.7M | $0.3M | $0.2M |
| Revenue growth | 251.0% | −34.6% | 38.3% | −47.7% | −41.5% |
| Net interest income | −$0.9M | −$3.3M | — | — | — |
| Gross margin | 60.0% | 94.5% | 81.5% | 79.5% | 78.5% |
| Operating margin | −6,912.6% | −10,234.5% | −6,198.8% | −9,676.3% | −11,541.5% |
| Net income | −$9.7M | −$29.9M | −$49.5M | −$39.4M | −$26.2M |
| Net margin | −1,347.2% | −6,325.2% | −7,569.4% | −11,520.5% | −13,086.5% |
| Diluted EPS | −$0.16 | — | — | — | — |
| Cash | |||||
| Cash from operations | −$34.6M | −$39.0M | −$30.2M | −$21.3M | −$18.5M |
| Capital expenditure | $1.3M | $5.2M | $0.3M | $0.0M | $0.0M |
| Free cash flow | −$36.0M | −$44.2M | −$30.5M | −$21.3M | −$18.6M |
| FCF margin | −4,973.2% | −9,342.5% | −4,663.8% | −6,240.1% | −9,292.5% |
| Share count change | 251.7% | — | — | — | — |
| Debt and strength | |||||
| Cash and short-term investments | $50.3M | $23.3M | $35.0M | $12.2M | $5.2M |
| Debt incl. finance leases | — | — | — | — | $17.8M |
| Shareholders' equity | $12.6M | $3.2M | $13.4M | −$8.9M | −$17.6M |
| Current ratio | 9.1x | 2.1x | 1.5x | 1.6x | 0.8x |
| Interest coverage | −57.4x | −14.7x | −8.9x | −8.1x | −8.6x |
| Returns and quality | |||||
| Return on equity | −150.6% | −377.9% | −595.5% | −1,738.4% | — |
| Return on tangible equity | −77.3% | −924.3% | −369.7% | — | — |
| Piotroski F-score | 3 | 1 | 2 | 3 | 1 |
| Altman Z'' | −8.5 | −19.1 | −18.3 | −40.6 | −65.2 |
Insiders bought, 12 months
$0.2M
1 insider
Insiders sold, 12 months
$5.8M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Clene Inc. · CLNN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.97 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001822791). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.